Valuation Yixintang Pharmaceutical Group Co., Ltd.

Stocks

End-of-day quote Shenzhen S.E. 30/09/2026			5-day change	1st Jan Change
10.72 ^CNY	+0.75%		-2.19%	-16.64%

09-16	Yixintang Pharmaceutical Group Co., Ltd. Announces Interim Cash Dividend for 2026 for A Shares, Payable on 24 September 2026	CI
08-27	Yixintang Pharmaceutical Group Co., Ltd. Proposes Interim Cash Dividend for 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	22,959	18,782	13,803	7,625	7,383	6,155	-	-
Change	-	-18.19%	-26.51%	-44.76%	-3.16%	-16.64%	-	-
Enterprise Value (EV) ¹	21,903	16,608	11,574	5,707	6,451	4,916	4,731	4,363
Change	-	-24.17%	-30.31%	-50.69%	13.04%	-23.8%	-3.76%	-7.77%
P/E	24.7x	18.6x	25.2x	67.6x	28.1x	13.7x	11.5x	9.49x
PBR	3.49x	2.53x	1.78x	1.02x	1.03x	0.83x	0.8x	0.76x
PEG	-	2.14x	-0.6x	-0.9x	0x	0.2x	0.6x	0.5x
Capitalization / Revenue	1.57x	1.08x	0.79x	0.42x	0.43x	0.35x	0.33x	0.31x
EV / Revenue	1.5x	0.95x	0.67x	0.32x	0.37x	0.28x	0.25x	0.22x
EV / EBITDA	16.9x	11x	10.6x	3.13x	9x	2.62x	2.25x	1.81x
EV / EBIT	20.5x	13.4x	11.8x	20.5x	15.3x	6.72x	5.61x	4.37x
EV / FCF	-	-	6.14x	3.89x	4.76x	4.47x	3.13x	2.32x
FCF Yield	-	-	16.3%	25.7%	21%	22.4%	31.9%	43.1%
Dividend per Share ²	0.3	0.4	0.4	0.3	0.2	0.3607	0.4926	0.6117
Rate of return	0.78%	1.27%	1.73%	2.3%	1.56%	3.36%	4.6%	5.71%
EPS ²	1.561	1.697	0.9206	0.1927	0.4571	0.7851	0.9351	1.13
Distribution rate	19.2%	23.6%	43.4%	156%	43.8%	45.9%	52.7%	54.1%
Net sales ¹	14,585	17,432	17,380	18,000	17,336	17,571	18,586	19,934
EBITDA ¹	1,295	1,511	1,087	1,823	716.6	1,874	2,101	2,411
EBIT ¹	1,066	1,243	982.9	278	422.4	731.7	844	997.9
Net income ¹	921.5	1,010	549.4	114.1	263.4	456.2	546.7	663.5
Net Debt ¹	-1,056	-2,174	-2,229	-1,917	-932	-1,239	-1,424	-1,791
Reference price ²	38.51	31.51	23.16	13.02	12.86	10.72	10.72	10.72
Nbr of stocks (in thousands)	596,181	596,071	596,005	585,604	574,128	574,128	-	-
Announcement Date	14/03/22	17/03/23	19/03/24	27/04/25	28/04/26	-	-	-

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
YIXINTANG PHARMACEUTICAL GROUP CO., LTD.	13.55x	0.28x	2.6x	3.39%	910M
JD HEALTH INTERNATIONAL INC.	16.43x	0.65x	9.74x	-.--%	14.65B
TSURUHA HOLDINGS INC.	20.22x	0.34x	5.46x	2.28%	6.08B
RAIA DROGASIL S.A.	21.23x	0.88x	9.32x	2.09%	6.06B
MATSUKIYOCOCOKARA & CO.	15.71x	0.7x	7.29x	2.37%	6.05B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	19.1x	0.7x	11.96x	1.13%	5.82B
YIFENG PHARMACY CHAIN CO., LTD.	14.8x	0.91x	6.36x	2.85%	4.16B
NAHDI MEDICAL COMPANY	14.23x	1.22x	7.48x	5.68%	3.15B
COSMOS PHARMACEUTICAL CORPORATION	15.15x	0.44x	7.29x	1.39%	3.08B
CLICKS GROUP LIMITED	14.85x	0.89x	6.7x	4.37%	3.04B
Average	16.53x	0.70x	7.42x	2.56%	5.3B
Weighted average by Cap.	17.15x	0.70x	8.33x	1.85%